Regulatory actions for June 24, 2026

Source Summary

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Arrowhead, Biokin, Calico, China Medical System, Diasorin, Draeger, ECM, Gilead, Lem, Orion, Portal, Quoin, Sanofi, Spotlight, Systimmune, US Worldmeds.